Reply to the letter by Dr. Ulas to the manuscript entitled: "Silybum marianum provides cardioprotection and limits adverse remodeling post-myocardial infarction by mitigating oxidative stress and reactive fibrosis"

Int J Cardiol. 2018 Nov 1:270:78. doi: 10.1016/j.ijcard.2018.07.056. Epub 2018 Jul 18.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antioxidants
  • Fibrosis
  • Humans
  • Myocardial Infarction
  • Oxidative Stress*
  • Silybum marianum*
  • Ventricular Remodeling

Substances

  • Antioxidants